Gossamer Bio Inc (GOSS): Total Asset Value of Company
The business of Gossamer Bio, Inc. (GOSS) relies on the development of a single drug for pulmonary hypertension, creating high regulatory dependency risks. Simultaneously, the company is implementing energy-saving technologies and emission filtration in its laboratories. This price visualization on GURU.Markets, which assists in the basic asset valuation, shows that total assets amount to 158.89, while drug production has been outsourced to third-party contractors to optimize costs.
Comprehensive metric breakdowns and analytics for Gossamer Corp (GOSS)
- price and consensus price forecast:
- market capitalization data:
- book capitalization data:
- debt and liquidity data:
All Debt to Shareholders' Equity Ratio Gossamer Bio, Inc.|GOSS - Long-Term Debt to Equity|Short-Term Debt to Equity Ratio Gossamer Bio Corp.|GOSS - Company Aggregate Debts|Debts to Book Capitalization Gossamer Bio Corp.|GOSS - Company Long-Term Liabilities|Company Short-Term Loans and Borrowings Gossamer Bio
Fundamental valuation:GOSS, gossamerbio.com
Gossamer Bio, Inc. (GOSS) requires significant capital expenditures in quality control infrastructure due to the complexities of managing biological substance logistics. A reverse calculation of total assets via ROA enables an assessment of resource efficiency by combining equity and liabilities to identify hidden balance sheet vulnerabilities; this total asset analysis confirms the company's financial resilience to macroeconomic shocks.
Competitors of Gossamer Bio, Inc. (GOSS)
ARGX (argenx.com) - Company Total Asset Base|Aggregate Company Assets BioNTech BNTX|Total Asset Value of Company Abivax|ADMA Bio (ADMA) - Company Total Assets|Aggregate Asset Value Protagonist Corp (PTGX)|Company Total Assets IMVT (Immunovant, Inc.)|kiniksa.com - Company Total Assets|Aggregate Company Assets Grifols (GRFS)|ADPT: Aggregate Asset Value|CLDX (Celldex) - Aggregate Company Assets|Aurinia Corp (AUPH) - Cumulative Company Assets|BCRX (BioCryst) - Company Total Assets|Company Total Assets veratx.com (VERA)|Dianthus Therapeutics, Inc. (DNTH) - Cumulative Company Assets|Aggregate Asset Value Pharvaris NV (PHVS)|Company Total Assets ABCL|Tourmaline - Company Total Asset Base|PGEN: Aggregate Company Assets|PHAR: Cumulative Company Assets|NKTR (Nektar Therapeutics Inc.) - Aggregate Company Assets|Cumulative Company Assets Upstream Bio, Inc.|ZBIO (Zenas Biopharma, Inc.) - Cumulative Company Assets|Company Total Assets IMNM|Aggregate Company Assets KalVista Pharmaceuticals KALV|Total Business Assets septerna.com (SEPN)|PVLA: Company Total Assets|Company Assets Savara Inc SVRA|Company Total Assets RIGL|ANAB: Company Balance Sheet Assets|Aggregate Company Assets ATXS|ENGN (engene.com) - Company Assets|RAPT: Aggregate Company Assets|Company Total Asset Base JBIO|ACRS (Aclaris) - Aggregate Company Assets|Company Total Asset Base Kyverna Therapeutics, Inc (KYTX)|Company Total Assets TLSA (Tiziana Life Sciences)|cabalettabio.com - Company Total Assets|VTYX: Aggregate Company Assets|THTX - Cumulative Company Assets|Company Total Assets AVTX|ELDN (Eledon Pharmaceuticals, Inc) - Company Assets|AGEN - Aggregate Company Assets|Aggregate Asset Value climbbio.com (CLYM)|Zura Bio (ZURA) - Cumulative Company Assets|Aggregate Asset Value aTyr Pharma Inc (ATYR)|Company Total Assets Adagene Inc. ADAG|Aggregate Company Assets ImageneBio IMA|Company Total Assets STTK (Shattuck Therapeutics)|EQ: Company Total Asset Base|Aggregate Company Assets CNTB|Company Assets Immunic|ATRA - Cumulative Company Assets|Aggregate Asset Value InflaRx GmbH|XFOR (X4 Pharmaceuticals) - Company Total Assets|Company Total Asset Base ACET (adicetbio.com)|CELU - Aggregate Company Assets|Total Business Assets INmune Bio Inc INMB|BRNS: Company Total Assets|Kezar Life Sciences Inc (KZR) - Cumulative Company Assets|SAB Biotherapeutics - Cumulative Company Assets|akaritx.com (AKTX) - Company Total Asset Base|Enlivex Therapeutics Ltd - Company Total Assets|Company Balance Sheet Assets QTTB|GeoVax Labs Inc - Aggregate Company Assets|Company Assets EDSA (Edesa Biotech Corp)|Aggregate Company Assets IBIO|Carisma Therapeutics Inc - Company Total Asset Base|Aggregate Company Assets XTLB (XTL Biopharmaceuticals Ltd.)|BOLT: Company Total Asset Base|Aggregate Company Assets hcwbiologics.com (HCWB)|Aptevo Therapeutics Inc. (APVO) - Total Asset Value of Company|AIM - Company Total Assets|Aggregate Asset Value Aditxt Corp|Company Total Assets GRI|Company Total Assets XRTX (XORTX Therapeutics Inc)|Aggregate Company Assets ReShape Lifesciences|Revelation Biosciences Corp - Aggregate Asset Value|INDP: Aggregate Company Assets|SCNI - Cumulative Company Assets|CALI: Company Total Assets|Company Total Assets Affimed N.V.|ALLK - Cumulative Company Assets|Aggregate Asset Value HOOKIPA|IGMS (IGM Biosciences, Inc.) - Company Total Assets|Company Total Asset Base ITOS (iteostherapeutics.com)|Ocean Biomedical - Aggregate Company Assets|TC BioPharm (Holdings) Plc - Cumulative Company Assets|THRD: Aggregate Company Assets